AstraZeneca's Christine Foster on CRT Trends & Quality Control

Add bookmark

"We have just started our journey, and I think we are going to continue to drive that performance." Christine Foster, AstraZeneca Maryann Gribbin, Director of Quality Assurance at Johnson & Johnson interviews Christine Foster, Global QA Audit Manager for AstraZeneca about the trends she is witnessing in the global shipments of Controlled Room Temperature (CRT) products, strategies for risk mitigation and shortening the learning curve.

RECOMMENDED